Rentokil Initial plc

As of June 30, 2026, Rentokil Initial plc carries a market capitalization of 12.45B, placing it among publicly traded companies globally. Its enterprise value stands at 15.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Rentokil Initial plc's next confirmed earnings release is scheduled for February 25, 2027.

As of June 30, 2026, Rentokil Initial plc has 2.52B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Rentokil Initial plc maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Rentokil Initial plc's stock has declined approximately 11.97% over the past 52 weeks. The 50-day moving average sits at 3.82, while the 200-day moving average is 4.90.

As of June 30, 2026, Rentokil Initial plc holds 2.16B in cash and equivalents against 5.33B in total debt, resulting in a net debt position of 2.69B. Total book value stands at 4.83B, with working capital of 216.20M providing operational flexibility.

Rentokil Initial plc's most recent stock split took place on May 19, 1997 with a 1:2 split ratio.